I have absolutely no idea but I gotta say, tunable stiffness and viscoelasticity are a big part of my positive lifestyle choices.
Vis-a-vis nothing, from an evolutionary functional perspective, it's not surprising that mechanical substrate profiles will play a part in immunomodulatory efficacy given that MSCs transform locally and specifically to the biochemical and tissue environment they are attracted to be it heart, gut, brain, etc via the vasculatory system of which they form a key part when engrafted to orchestrate local healing.
Cell Therapy News/Articles, page-17823
-
- There are more pages in this discussion • 605 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.501B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.436M | 1.104M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 16606 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 34883 | 11 |
View Market Depth
| Last trade - 14.59pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |